For patients with Epithelioid Sarcoma looking for a trial option, our study with ubamatamab may be of interest. Now open and enrolling!
Reposted from
Pavlos Msaouel
Excited to activate our fourth clinical trial designed for #RenalMedullaryCarcinoma (RMC). It is enrolling patients with epithelioid sarcoma, another rare but deadly cancer defined by loss of the SMARCB1 tumor suppressor: clinicaltrials.gov/study/NCT064...
Comments